ACTUAL QUESTIONS & VERIFIED ANSWERS | UNIVERSITY
OF SOUTH CAROLINA | GUARANTEE PASS
NURS 711 FINAL EXAMINATION – PHARMACOTHERAPIES
2026 Comprehensive Practice Examination
University of South Carolina
Course: NURS 711 – Pharmacotherapies for Nursing Practice
Academic Year: 2026
Document type: Original comprehensive practice examination with answers and rationales
Table of Contents
1. Introduction & Pharmacologic Foundations — Questions 1–40
2. Core Pharmacokinetics, Pharmacodynamics & Medication Safety — Questions 41–80
3. Cardiovascular, Renal & Hematologic Pharmacotherapy — Questions 81–120
4. Endocrine, Respiratory, Gastrointestinal & Infectious-Disease Pharmacotherapy —
Questions 121–160
5. Applied Clinical Scenarios & Critical Thinking — Questions 161–190
6. Comprehensive Review & Integration — Questions 191–200
SECTION I — INTRODUCTION & PHARMACOLOGIC FOUNDATIONS
Question 1
Which pharmacologic term describes the study of what a drug does to the body?
A. Pharmacokinetics
B. Pharmacodynamics
C. Pharmacogenomics
D. Pharmaceutics
Correct answer: B. Pharmacodynamics
Rationale: Pharmacodynamics concerns the biochemical and physiologic effects of drugs and
their mechanisms of action. Pharmacokinetics describes what the body does to a drug through
absorption, distribution, metabolism, and excretion.
,Question 2
Which sequence correctly represents the major pharmacokinetic processes?
A. Distribution, absorption, excretion, metabolism
B. Absorption, distribution, metabolism, excretion
C. Metabolism, absorption, distribution, excretion
D. Absorption, metabolism, distribution, excretion
Correct answer: B. Absorption, distribution, metabolism, excretion
Rationale: ADME summarizes the major pharmacokinetic processes. The sequence is absorption
into systemic circulation, distribution to tissues, metabolism—often hepatic—and elimination,
commonly through renal or biliary pathways.
Question 3
A medication administered intravenously has what approximate bioavailability?
A. 25%
B. 50%
C. 75%
D. 100%
Correct answer: D. 100%
Rationale: IV administration delivers the medication directly into systemic circulation, so the
administered dose is considered completely bioavailable. Oral medications may have lower
bioavailability because of incomplete absorption and first-pass metabolism.
Question 4
Which route most directly avoids hepatic first-pass metabolism?
A. Oral
B. Sublingual
C. Enteric-coated oral
D. Gastric tube
Correct answer: B. Sublingual
Rationale: Drugs absorbed through the sublingual mucosa enter systemic circulation without
initially passing through the portal circulation. This can provide rapid onset and avoid substantial
first-pass hepatic metabolism.
Question 5
A drug's half-life is best defined as the time required for:
,A. Complete elimination of the drug
B. The drug to begin producing an effect
C. Plasma drug concentration to decrease by approximately 50%
D. The drug to reach peak concentration
Correct answer: C. Plasma drug concentration to decrease by approximately 50%
Rationale: Half-life is the time needed for plasma concentration to fall by approximately one-
half during the elimination phase. It helps determine dosing intervals and the approximate time
required to reach steady state.
Question 6
A medication with a narrow therapeutic index requires particular attention to:
A. Tablet color
B. Therapeutic drug monitoring
C. Administration only with food
D. Increasing the dose until symptoms disappear
Correct answer: B. Therapeutic drug monitoring
Rationale: Drugs with a narrow therapeutic index have relatively little separation between
effective and toxic concentrations. Monitoring serum concentrations, clinical response, and
adverse effects can therefore be important.
Question 7
An agonist is a drug that:
A. Binds to a receptor and produces a response
B. Permanently destroys a receptor
C. Prevents every physiologic response
D. Always produces toxicity
Correct answer: A. Binds to a receptor and produces a response
Rationale: An agonist has affinity for a receptor and intrinsic activity that produces a
physiologic or pharmacologic response. An antagonist binds but blocks or reduces receptor
activation.
Question 8
Which drug characteristic generally increases the ability to cross lipid membranes?
A. High lipid solubility
B. Permanent ionization
, C. Large molecular size
D. Complete protein binding
Correct answer: A. High lipid solubility
Rationale: Lipid-soluble molecules generally cross biologic membranes more readily.
Ionization, molecular size, protein binding, and tissue characteristics also influence distribution.
Question 9
A patient asks why a medication is being titrated slowly. The most appropriate general
explanation is:
A. All medications require slow titration
B. Gradual adjustment can reduce adverse effects while identifying the effective dose
C. Titration eliminates all drug interactions
D. Titration guarantees treatment success
Correct answer: B. Gradual adjustment can reduce adverse effects while identifying the
effective dose
Rationale: Some medications require gradual dose adjustment to balance efficacy and
tolerability. The specific titration schedule depends on the drug, indication, patient
characteristics, and clinical response.
Question 10
Which factor can significantly alter medication pharmacokinetics in an older adult?
A. Reduced renal function
B. Increased total body water in every patient
C. Guaranteed increased hepatic metabolism
D. Elimination of all drug interactions
Correct answer: A. Reduced renal function
Rationale: Aging may be associated with decreased renal function, altered hepatic metabolism,
changes in body composition, and increased sensitivity to some medications. Renal function
should therefore be considered when dosing renally eliminated drugs.
Question 11
A medication described as a competitive antagonist generally:
A. Activates the receptor more strongly than an agonist
B. Competes with an agonist for receptor binding
C. Irreversibly increases receptor number
D. Has no receptor affinity